What is she best known for?
The fields of study she is best known for:
- Virus
- Internal medicine
- Acquired immunodeficiency syndrome
Her main research concerns Virology, Lentivirus, Drug resistance, Genotype and Viral load.
Her Virology study combines topics in areas such as Integrase, Acquired immunodeficiency syndrome and Immunology.
Her biological study deals with issues like Internal medicine, which deal with fields such as Ritonavir.
Her Lentivirus study is associated with Virus.
The various areas that Carmen de Mendoza examines in her Drug resistance study include Gastroenterology, Sida, Reverse-transcriptase inhibitor and Polymerase chain reaction, Nested polymerase chain reaction.
Her work on BDNA test as part of general Viral load research is often related to Dried blood, thus linking different fields of science.
Her most cited work include:
- Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management (389 citations)
- Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach (114 citations)
- Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes (107 citations)
What are the main themes of her work throughout her whole career to date?
Virology, Drug resistance, Immunology, Internal medicine and Virus are her primary areas of study.
She focuses mostly in the field of Virology, narrowing it down to topics relating to Genotype and, in certain cases, Integrase.
Her biological study spans a wide range of topics, including Protease inhibitor, Resistance mutation, Reverse transcriptase, Mutation and Regimen.
Many of her research projects under Internal medicine are closely connected to In patient with In patient, tying the diverse disciplines of science together.
Her research in Virus intersects with topics in Hepatitis B, Antibody and Drug.
Her research investigates the connection between Viral disease and topics such as Acquired immunodeficiency syndrome that intersect with problems in Epidemiology.
She most often published in these fields:
- Virology (62.50%)
- Drug resistance (28.02%)
- Immunology (27.16%)
What were the highlights of her more recent work (between 2017-2021)?
- Virology (62.50%)
- Internal medicine (22.84%)
- HTLV-1 Infection (2.59%)
In recent papers she was focusing on the following fields of study:
Carmen de Mendoza spends much of her time researching Virology, Internal medicine, HTLV-1 Infection, In patient and Virus.
Her Virology research is multidisciplinary, incorporating perspectives in Integrase inhibitor, Drug resistance and Genotype.
Her study looks at the relationship between Drug resistance and topics such as Rilpivirine, which overlap with Intensive care medicine.
In her study, Hepatitis C virus is inextricably linked to Gastroenterology, which falls within the broad field of Internal medicine.
Her Virus study combines topics from a wide range of disciplines, such as Hepatitis B, Hepatitis C and Hepatocellular carcinoma.
She works mostly in the field of Tropical spastic paraparesis, limiting it down to topics relating to Transmission and, in certain cases, Acquired immunodeficiency syndrome.
Between 2017 and 2021, her most popular works were:
- Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection. (29 citations)
- Treatment and prevention of HIV infection with long-acting antiretrovirals (26 citations)
- HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors (22 citations)
In her most recent research, the most cited papers focused on:
- Acquired immunodeficiency syndrome
- Internal medicine
- Virus
The scientist’s investigation covers issues in Internal medicine, Hepatitis C, Incidence, HTLV-1 Infection and Human T-lymphotropic virus 1.
Her Internal medicine research incorporates themes from Coinfection and Serology.
Her Coinfection research includes elements of Treatment outcome, Viremia, Acquired immunodeficiency syndrome, Viral load and Retrospective cohort study.
Virology covers Carmen de Mendoza research in Hepatitis C.
Her studies deal with areas such as Global health, Epidemiology, Young adult and Environmental health as well as Incidence.
Her HTLV-1 Infection research integrates issues from Outcome assessment, Dialysis, HTLV-I infections and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
